ProductLife boosts drug development with IntiQuan acquisition
ProductLife Group (PLG) has announced the acquisition of IntiQuan, a Swiss firm specialising in pharmacometrics. The move enhances PLG's capabilities…
All articles by RanjithKumar Dharma
RanjithKumar Dharma
-
-
Health Canada approves Telix’s Illuccix label expansion
Health Canada has expanded the approved use of Telix Pharmaceuticals' Illuccix for patient selection in prostate-specific membrane antigen (PSMA) targeted…
-
OnKure and Reneo Pharmaceuticals complete merger
OnKure has announced the successful completion of its merger with Reneo Pharmaceuticals, with the combined entity set to operate under…
-
NUHS’s CD7 CAR-T cell therapy shows promise for leukaemia
Singapore's National University Health System (NUHS) has announced that a new cluster of differentiation (CD7) chimeric antigen receptor (CAR)-T cell…
-
Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment specifically targeting…
-
Teva and mAbxience partner to develop biosimilar candidate for oncology
Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti programmed cell death protein…
-
BMS receives FDA approval for Opdivo to treat NSCLC
Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults…
-
Resilience secures funds to enhance production of essential medicine components
National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical medicine components manufacturing. Resilience received…
-
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer
ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer and evaluation agreement (MTEA) with…
-
Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy
Novaliq and Laboratoires Théa have announced approval from the European Commission (EC) for Vevizye (ciclosporin 0.1% eye drops solution) for…